facebook
TradedTraded
    Home
    Deals
    Newsletter
    Articles
    PropTech
    Partners


Messages

Go Pro
+ Submit+ Submit
All Deals
October 27, 2025 - Deals

Todd Glaser Acquires Historic 1834 Hannibal French House In Sag Harbor For $16.25M

Property Image
SALE IMAGE: Todd Glaser & Susan Breitenbach DATE: 10/27/2025 ADDRESS: 186 Main Street MARKET: Sag Harbor ASSET TYPE: Single Family BUYER: Todd Glaser SELLER'S REP: Susan Breitenbach - The Corcoran Group (@TheCorcoranGroup) BUYER'S REP: Bespoke Real Estate (@Bespoke.RealEstate) SALE PRICE: $16,250,000 SF: 6,500 ~ PPSF: $2,500 NOTE: Miami developer Todd Glaser paid $16.25 million for the historic 1834 Hannibal French House at 186 Main Street in Sag Harbor, marking his first major move into the Hamptons. Known for high-end South Florida projects, Glaser said he plans to focus on renovations rather than new builds in the area, calling the Sag Harbor home his wife’s “dream house.” #NewYork #RealEstate #TradedNY #NY #NewYorkRealEstate #NYCRealEstate #ToddGlaser #SagHarbor #SingleFamily #SusanBreitenbach #TheCorcoranGroup

Property Image
Colossal Biosciences In Talks For Funding Round Targeting $23 Billion ValuationColossal Biosciences, the de-extinction biotech startup known for its efforts to recreate the woolly mammoth and other extinct species, is reportedly in talks to raise new funding at a valuation of roughly $23 billion–$24 billion, according to Axios. The potential raise would mark a significant jump for the five-year-old company, with investors valuing not only its genetic-engineering programs but also its broader genomics, reproductive technology, conservation, and intellectual property platform. Colossal has begun generating revenue through conservation technology sales and technology spinouts, including Astromech, an AI-driven predictive modeling company, and Form Bio, a computational biology platform, expanding its value beyond de-extinction efforts. FOUNDERS: Ben Lamm & George Church TARGET VALUATION: $23,000,000,000 HQ: Dallas, Texas #VentureCapital #ColossalBiosciences #BenLamm #GeorgeChurch #TradedVC